Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

NCT05344482 · clinicaltrials.gov ↗

COMPLETED

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

OTHER: Secukinumab

Sponsor

Novartis Pharmaceuticals